The global sales of the In-vitro toxicology testing market in 2021 was held at US$ 24.1 Bn. With 13%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth.
The absolute dollar opportunity for the market is projected at US$ 64.3 Bn during the forecast period. One of the key market drivers is significant breakthroughs in toxicity science. Furthermore, the high costs associated with traditional animal tests as well as the socio-ethical considerations connected with animal experiments are expected to drive the expansion of the market for in-vitro toxicological testing.
As per the market research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the market increased at around 11.3% CAGR, wherein, North America held a significant share in the global market.
Early-stage adverse events discovered through in-vitro toxicity testing can help prevent serious adverse events throughout the majority of drug discovery projects, which is why the development of dozens of medicines projected to drive the market for in-vitro toxicity testing. Since November 2020, 590 drugs were under development in relation to coronavirus. A large number of drug development initiatives are expected to increase the demand for In-vitro Toxicology Testing services. As a result, the market is expected to grow at a CAGR of 13% over the next ten years.
Significant improvements in in-vitro toxicology tests to evaluate medicinal product safety, as well as the evaluation of medicines' potential influence on cells and tissues, are expected to boost revenue creation in the market. With the increased need for such assays, firms have widened their offering to meet the demand for in-vitro toxicity testing. The availability of various tools in the biotechnology and bioinformatics divisions to do in-silico simulations on animal models is also affecting business growth. Furthermore, the growth of toxicology databases for the in-silico study of various chemicals is expected to drive demand for in-vitro procedures, resulting in industry propagation.
Significant government support for research, combined with specific reimbursement rules, is intended to improve market stability by developing automated and technologically sophisticated equipment for laboratory analysis and ex-vivo examinations. On the contrary, the lack of immunity testing and immune stimulation in present in-vitro tests is likely to stymie the industry's expansion.
North America has been a significant contributor to the In-vitro toxicology testing market revenues with a projected market of over US$ 36 Bn by 2032. The market in the region is expected to grow at a CAGR of over 11% during 2022 – 2032.
The ongoing introduction of biologics and biosimilar drugs by biopharmaceutical producers in the United States fuels demand for in-vitro toxicity testing in North America. Furthermore, government authorities are participating in drug discovery investment and funding projects. Some of the entities actively involved in investment in basic drug discovery research and improving the use of alternative modalities of toxicity testing in the United States are the National Institutes of Health and the Defense Advanced Research Projects Agency.
The US leads the global market, which is projected to reach US$ 32.4 billion by 2032 rising at a CAGR of 11.7% during the forecast period. In the United States, reimbursement and technical advancement facilities are positive considerations.
An increased emphasis on drug discovery by government bodies, an increase in healthcare expenditure, and the provision of suitable infrastructure for the growth and development of drug discovery technologies have been the key market drivers in the U.S. Furthermore, strict regulatory standards for medication development and approval have increased the use of in-vitro toxicity testing services in the market.
The market in the U.K. is expected to reach a valuation of US$ 4.2 Bn by 2032, growing at a CAGR of 16%. During 2022 – 2032, the market is projected to gross an absolute dollar opportunity of US$ 3.2 Bn.
In Japan, the market is projected to be valued at US$ 3.2 Bn by 2032. The market in the country is expected to gross an absolute dollar opportunity of US$ 2.3 Bn during the forecast period, growing at a CAGR of 13.8%.
The market in South Korea is expected to be valued at US$ 2.2 Bn by 2032. The market is projected to gross an absolute dollar opportunity of US$ 1.6 Bn, growing at a CAGR of 14.6% during 2022 – 2032.
Due to the rising drug discovery screening to detect cytotoxicity and other bio-chemicals, cellular assay compliance with the requirement specification segment dominated the market in 2021. The introduction of new products for testing cannabis-based pharmaceuticals is hastening the industry's expansion. The market through cellular assay will expand at a CAGR of 15.2% throughout the forecast period.
In the early phases of medication development, numerous pharmaceutical and biotech businesses rely heavily on cellular tests for toxicity screening. In-vitro cell viability tests provide various advantages, including low cost, quick results, and the opportunity for automation. These assays, however, present significant technical issues and are yet to totally replace animal testing, creating challenges to their expansion. The ex-vivo segment, on the other hand, is projected to increase at a rapid pace throughout the projection period.
Ex-vivo or tiny explant cultures allow drug screening tests to be carried out in a sterile, regulated, and dynamic environment while preserving the natural architecture of the tissues. The fact that the ex-vivo model performs tests or detections outside the organism is a significant benefit.
Some of the key companies operating in the global In-vitro Toxicology Testing industry include Merck KGaA, Charles River, Bio-Rad Laboratories, Inc., Abbott, Thermo Fisher Scientific Inc., Catalent, Inc., GE Healthcare, Quest Diagnostics Incorporated, Eurofins Scientific, Laboratory Corporation of America Holdings, Evotec, Creative Bioarray, Gentronix, BioIVT, SGS SA, and Agilent Technologies among others.
The recent developments in in-vitro toxicology testing market are:
By Method
By End-use
By Technology
By Application
By Region
|
Attribute |
Details |
|
Global Market Size (2022) |
US$ 27 Bn |
|
Global Market Size (2032) |
US$ 91.3 Bn |
|
Global Market CAGR (2022 – 2032) |
13% |
|
U.S. Market CAGR (2022 – 2032) |
11.7% |
|
Key Companies Profiled |
|
The global market is worth more than US$ 27Bn at present.
The market value is projected to increase at a CAGR of around 13% during 2022 – 2032.
The market value increased at a CAGR of around 11.3% during 2017 – 2021.
The top 5 countries driving demand for the in-vitro toxicology testing market are the U.S., China, the UK, Japan, and South Korea.
The key method having the highest demand is Cellular Assay which will be accounted for 15.2% CAGR during 2022-2032.
The US market for In-vitro Toxicology Testing is projected to expand at a CAGR of around 11.7% during 2022 – 2032.
The key companies are Merck KGaA, Charles River, Bio-Rad Laboratories, Inc., Abbott, Thermo Fisher Scientific Inc., Catalent, Inc., GE Healthcare, Quest Diagnostics Incorporated, Eurofins Scientific, Laboratory Corporation of America Holdings, Evotec, Creative Bioarray, Gentronix, BioIVT, SGS SA, and Agilent Technologies among others.
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage
2.2. Market Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on In-vitro Toxicology Testing Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. In-vitro Toxicology Testing Market, by Key Countries
4.2. In-vitro Toxicology Testing Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. In-vitro Toxicology Testing Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. In-vitro Toxicology Testing Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global In-vitro Toxicology Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2017-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global In-vitro Toxicology Testing Market Value Analysis 2017-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Method
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Method, 2017-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Method, 2022-2032
8.3.1. Cellular Assay
8.3.1.1. Live Cells
8.3.1.2. Fixed Cells
8.3.2. Biochemical Assay
8.3.3. In-Silico
8.3.4. Ex-vivo
8.4. Market Attractiveness Analysis By Method
9. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End-use
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End-use, 2017-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-use, 2022-2032
9.3.1. Pharmaceutical Industry
9.3.2. Cosmetics & Household Products
9.3.3. Academic Institutes and Research Laboratories
9.3.4. Diagnostics
9.3.5. Chemical Industry
9.3.6. Food Industry
9.4. Market Attractiveness Analysis By End-use
10. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Technology
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Technology, 2017-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022-2032
10.3.1. Cell Culture Technology
10.3.2. High Throughput Technology
10.3.3. Molecular Imaging
10.3.4. OMICS Technology
10.4. Market Attractiveness Analysis By Technology
11. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Application, 2017-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032
11.3.1. Systemic Toxicology
11.3.2. Dermal Toxicity
11.3.3. Endocrine Disruption
11.3.4. Occular Toxicity
11.3.5. Other Applications
11.4. Market Attractiveness Analysis By Application
12. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021
12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Method
13.4.3. By End-use
13.4.4. By Application
13.4.5. By Technology
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Method
13.5.3. By End-use
13.5.4. By Application
13.5.5. By Technology
14. Latin America In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Method
14.4.3. By End-use
14.4.4. By Application
14.4.5. By Technology
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Method
14.5.3. By End-use
14.5.4. By Application
14.5.5. By Technology
15. Europe In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. U.K.
15.4.1.4. Italy
15.4.1.5. Benelux
15.4.1.6. Nordic Countries
15.4.1.7. Rest of Europe
15.4.2. By Method
15.4.3. By End-use
15.4.4. By Application
15.4.5. By Technology
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Method
15.5.3. By End-use
15.5.4. By Application
15.5.5. By Technology
16. Asia Pacific In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of Asia Pacific
16.4.2. By Method
16.4.3. By End-use
16.4.4. By Application
16.4.5. By Technology
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Method
16.5.3. By End-use
16.5.4. By Application
16.5.5. By Technology
17. Middle East and Africa In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Turkey
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Method
17.4.3. By End-use
17.4.4. By Application
17.4.5. By Technology
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Method
17.5.3. By End-use
17.5.4. By Application
17.5.5. By Technology
18. Key Countries In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US In-vitro Toxicology Testing Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.2.2.1. By Method
18.2.2.2. By End-use
18.2.2.3. By Application
18.2.2.4. By Technology
18.3. Canada In-vitro Toxicology Testing Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.3.2.1. By Method
18.3.2.2. By End-use
18.3.2.3. By Application
18.3.2.4. By Technology
18.4. Mexico In-vitro Toxicology Testing Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.4.2.1. By Method
18.4.2.2. By End-use
18.4.2.3. By Application
18.4.2.4. By Technology
18.5. Brazil In-vitro Toxicology Testing Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.5.2.1. By Method
18.5.2.2. By End-use
18.5.2.3. By Application
18.5.2.4. By Technology
18.6. Germany In-vitro Toxicology Testing Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.6.2.1. By Method
18.6.2.2. By End-use
18.6.2.3. By Application
18.6.2.4. By Technology
18.7. France In-vitro Toxicology Testing Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.7.2.1. By Method
18.7.2.2. By End-use
18.7.2.3. By Application
18.7.2.4. By Technology
18.8. Italy In-vitro Toxicology Testing Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.8.2.1. By Method
18.8.2.2. By End-use
18.8.2.3. By Application
18.8.2.4. By Technology
18.9. BENELUX In-vitro Toxicology Testing Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.9.2.1. By Method
18.9.2.2. By End-use
18.9.2.3. By Application
18.9.2.4. By Technology
18.10. UK In-vitro Toxicology Testing Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.10.2.1. By Method
18.10.2.2. By End-use
18.10.2.3. By Application
18.10.2.4. By Technology
18.11. Nordic Countries In-vitro Toxicology Testing Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.11.2.1. By Method
18.11.2.2. By End-use
18.11.2.3. By Application
18.11.2.4. By Technology
18.12. China In-vitro Toxicology Testing Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.12.2.1. By Method
18.12.2.2. By End-use
18.12.2.3. By Application
18.12.2.4. By Technology
18.13. Japan In-vitro Toxicology Testing Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.13.2.1. By Method
18.13.2.2. By End-use
18.13.2.3. By Application
18.13.2.4. By Technology
18.14. South Korea In-vitro Toxicology Testing Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.14.2.1. By Method
18.14.2.2. By End-use
18.14.2.3. By Application
18.14.2.4. By Technology
18.15. GCC Countries In-vitro Toxicology Testing Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.15.2.1. By Method
18.15.2.2. By End-use
18.15.2.3. By Application
18.15.2.4. By Technology
18.16. South Africa In-vitro Toxicology Testing Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.16.2.1. By Method
18.16.2.2. By End-use
18.16.2.3. By Application
18.16.2.4. By Technology
18.17. Turkey In-vitro Toxicology Testing Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.17.2.1. By Method
18.17.2.2. By End-use
18.17.2.3. By Application
18.17.2.4. By Technology
18.17.3. Competition Landscape and Player Concentration in the Country
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. MERCK KGAA
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. CHARLES RIVER
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. BIO-RAD LABORATORIES, INC.
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. ABBOTT
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. THERMO FISHER SCIENTIFIC INC.
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. CATALENT, INC.
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.7. GE HEALTHCARE
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Strategy Overview
20.3.8. QUEST DIAGNOSTICS INCORPORATED
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.9. EUROFINS SCIENTIFIC
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Strategy Overview
20.3.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview
20.3.11. EVOTEC
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Sales Footprint
20.3.11.4. Strategy Overview
20.3.12. CREATIVE BIOARRAY
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Sales Footprint
20.3.12.4. Strategy Overview
20.3.13. GENTRONIX
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Sales Footprint
20.3.13.4. Strategy Overview
20.3.14. BIOIVT
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Sales Footprint
20.3.14.4. Strategy Overview
20.3.15. SGS SA
20.3.15.1. Overview
20.3.15.2. Product Portfolio
20.3.15.3. Sales Footprint
20.3.15.4. Strategy Overview
20.3.16. AGILENT TECHNOLOGIES
20.3.16.1. Overview
20.3.16.2. Product Portfolio
20.3.16.3. Sales Footprint
20.3.16.4. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology
List of Tables
Table 1: Global In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021
Table 2: Global In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032
Table 3: Global In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021
Table 4: Global In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032
Table 5: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021
Table 6: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032
Table 7: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021
Table 8: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032
Table 9: Global In-vitro Toxicology Testing Market, By Region, 2017 – 2021
Table 10: Global In-vitro Toxicology Testing Market, By Region, 2022 – 2032
Table 11: North America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021
Table 12: North America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032
Table 13: North America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021
Table 14: North America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032
Table 15: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021
Table 16: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032
Table 17: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021
Table 18: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032
Table 19: North America In-vitro Toxicology Testing Market, By Country, 2017 – 2021
Table 20: North America In-vitro Toxicology Testing Market, By Country, 2022 – 2032
Table 21: Latin America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021
Table 22: Latin America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032
Table 23: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021
Table 24: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032
Table 25: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021
Table 26: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032
Table 27: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021
Table 28: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032
Table 29: Latin America In-vitro Toxicology Testing Market, By Country, 2017 – 2021
Table 30: Latin America In-vitro Toxicology Testing Market, By Country, 2022 – 2032
Table 31: Europe In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021
Table 32: Europe In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032
Table 33: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021
Table 34: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032
Table 35: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021
Table 36: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032
Table 37: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021
Table 38: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032
Table 39: Europe In-vitro Toxicology Testing Market, By Country, 2017 – 2021
Table 40: Europe In-vitro Toxicology Testing Market, By Country, 2022 – 2032
Table 41: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021
Table 42: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032
Table 43: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021
Table 44: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032
Table 45: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021
Table 46: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032
Table 47: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021
Table 48: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032
Table 49: Asia Pacific In-vitro Toxicology Testing Market, By Country, 2017 – 2021
Table 50: Asia Pacific In-vitro Toxicology Testing Market, By Country, 2022 – 2032
Table 51: MEA In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 – 2021
Table 52: MEA In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 – 2032
Table 53: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 – 2021
Table 54: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 – 2032
Table 55: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 – 2021
Table 56: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 – 2032
Table 57: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 – 2021
Table 58: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 – 2032
Table 59: MEA In-vitro Toxicology Testing Market, By Country, 2017 – 2021
Table 60: MEA In-vitro Toxicology Testing Market, By Country, 2022 – 2032
List of Figures
Figure 1: Global In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
Figure 2: Global In-vitro Toxicology Testing Market Absolute $ Historical Gain (2017 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032
Figure 4: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method – 2022-2032
Figure 5: Global In-vitro Toxicology Testing Market Attractiveness Index, By Method – 2022-2032
Figure 6: Global In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032
Figure 7: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use – 2022-2032
Figure 8: Global In-vitro Toxicology Testing Market Attractiveness Index, By End-use – 2022-2032
Figure 9: Global In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032
Figure 10: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 11: Global In-vitro Toxicology Testing Market Attractiveness Index, By Application – 2022-2032
Figure 12: Global In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032
Figure 13: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 14: Global In-vitro Toxicology Testing Market Attractiveness Index, By Technology – 2022-2032
Figure 15: Global In-vitro Toxicology Testing Market Share, By Region, 2022 & 2032
Figure 16: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 17: Global In-vitro Toxicology Testing Market Attractiveness Index, By Region – 2022-2032
Figure 18: North America In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
Figure 19: North America In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 20: North America In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032
Figure 21: North America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method – 2022-2032
Figure 22: North America In-vitro Toxicology Testing Market Attractiveness Index, By Method – 2022-2032
Figure 23: North America In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032
Figure 24: North America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use – 2022-2032
Figure 25: North America In-vitro Toxicology Testing Market Attractiveness Index, By End-use – 2022-2032
Figure 26: North America In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032
Figure 27: North America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 28: North America In-vitro Toxicology Testing Market Attractiveness Index, By Application – 2022-2032
Figure 29: North America In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032
Figure 30: North America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 31: North America In-vitro Toxicology Testing Market Attractiveness Index, By Technology – 2022-2032
Figure 32: North America In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032
Figure 33: North America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 34: North America Market Attractiveness Index, By Country – 2022-2032
Figure 35: Latin America In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
Figure 36: Latin America In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 37: Latin America In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032
Figure 38: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method – 2022-2032
Figure 39: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By Method – 2022-2032
Figure 40: Latin America In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032
Figure 41: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use – 2022-2032
Figure 42: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By End-use – 2022-2032
Figure 43: Latin America In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032
Figure 44: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 45: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By Application – 2022-2032
Figure 46: Latin America In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032
Figure 47: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 48: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By Technology – 2022-2032
Figure 49: Latin America In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032
Figure 50: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 51: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By Country – 2022-2032
Figure 52: Europe In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
Figure 53: Europe In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 54: Europe In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032
Figure 55: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method – 2022-2032
Figure 56: Europe In-vitro Toxicology Testing Market Attractiveness Index, By Method – 2022-2032
Figure 57: Europe In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032
Figure 58: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use – 2022-2032
Figure 59: Europe In-vitro Toxicology Testing Market Attractiveness Index, By End-use – 2022-2032
Figure 60: Europe In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032
Figure 61: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 62: Europe In-vitro Toxicology Testing Market Attractiveness Index, By Application – 2022-2032
Figure 63: Europe In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032
Figure 64: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 65: Europe In-vitro Toxicology Testing Market Attractiveness Index, By Technology – 2022-2032
Figure 66: Europe In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032
Figure 67: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 68: Europe In-vitro Toxicology Testing Market Attractiveness Index, By Country – 2022-2032
Figure 69: MEA In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
Figure 70: MEA In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 71: MEA In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032
Figure 72: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method – 2022-2032
Figure 73: MEA In-vitro Toxicology Testing Market Attractiveness Index, By Method – 2022-2032
Figure 74: MEA In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032
Figure 75: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use – 2022-2032
Figure 76: MEA In-vitro Toxicology Testing Market Attractiveness Index, By End-use – 2022-2032
Figure 77: MEA In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032
Figure 78: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 79: MEA In-vitro Toxicology Testing Market Attractiveness Index, By Application – 2022-2032
Figure 80: MEA In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032
Figure 81: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 82: MEA In-vitro Toxicology Testing Market Attractiveness Index, By Technology – 2022-2032
Figure 83: MEA In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032
Figure 84: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 85: MEA In-vitro Toxicology Testing Market Attractiveness Index, By Country – 2022-2032
Figure 86: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
Figure 87: Asia Pacific In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 88: Asia Pacific In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032
Figure 89: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method – 2022-2032
Figure 90: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By Method – 2022-2032
Figure 91: Asia Pacific In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032
Figure 92: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use – 2022-2032
Figure 93: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By End-use – 2022-2032
Figure 94: Asia Pacific In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032
Figure 95: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 96: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By Application – 2022-2032
Figure 97: Asia Pacific In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032
Figure 98: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 99: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By Technology – 2022-2032
Figure 100: Asia Pacific In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032
Figure 101: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 102: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By Country – 2022-2032
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
In-vitro Toxicology Testing Market
*86 figures and 60 tables includes